Status:
COMPLETED
Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation
Lead Sponsor:
Kurume University
Conditions:
Atherosclerosis
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether FDG-PET is capable of detecting atherosclerotic plaque inflammation and monitoring the effects of statins on plaque inflammation. The usefulness of FD...
Detailed Description
There is increasing evidence that inflammation plays a role in progression and destabilization of atherosclerotic plaque. However, currently, no non-invasive method is available for detecting plaque i...
Eligibility Criteria
Inclusion
- Protocol 1: patients who had carotid atherosclerosis detected by carotid ultrasound.
- Protocol 2: patients who underwent FDG-PET for cancer screening and had vascular FDG uptakes
Exclusion
- Active inflammatory diseases
- Dyslipidemia under medications
- Uncontrolled diabetes mellitus, vasculitis, symptomatic coronary artery disease, symptomatic cerebrovascular diseases
- Known systemic disorders such as hepatic, renal, hematopoietic, and malignant diseases
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00114504
Start Date
September 1 2004
End Date
April 1 2009
Last Update
June 1 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kurume University Hospital
Kurume, Japan, 830-0011